Case Study: Giant Cell Arteritis with Vertebral Artery Stenosis
| Autor: | Farshad Ghazanfari, R. Daniel Chomlak, Mineesh Datta |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Pathology lcsh:Diseases of the musculoskeletal system Vertebral artery Case Report vertebral artery stenosis 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Tocilizumab Rheumatology medicine.artery Vertigo Occlusion Immunology and Allergy Medicine skin and connective tissue diseases 030203 arthritis & rheumatology biology business.industry giant cell arteritis Cancer medicine.disease biology.organism_classification Giant cell arteritis medicine.anatomical_structure chemistry Upper limb Radiology lcsh:RC925-935 business Complication 030217 neurology & neurosurgery |
| Zdroj: | Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, Vol 2016, Iss 9, Pp 103-107 (2016) Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, Vol 9 (2016) |
| ISSN: | 1179-5441 |
| Popis: | In giant cell arteritis (GCA), involvement of the vertebral arteries is rare with reported rates of 3%–4% for ischemic events secondary to vertebral artery stenosis or occlusion for those patients with GCA. This case study describes a patient who initially presented with acute onset of vertigo but was also found to have transient, side-alternating upper limb neurological findings. While initial imaging showed no vascular abnormalities, it was not until GCA was eventually confirmed with a temporal artery biopsy that the initial scans were shown to have bilateral narrowing of the vertebral arteries. While rare, vertebral artery involvement is an important complication to consider in the setting of GCA due to the high rate of associated mortality, despite immunosuppressive therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|